A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients

Computer Methods and Programs in Biomedicine

Volumn 102, Issue 2, 2011, Pages 192-205

  Lin, Jessica ^a   Razak, Normy N ^b   Pretty, Christopher G ^b   Le Compte, Aaron ^b   Docherty, Paul ^b   Parente, Jacquelyn D ^b   Shaw, Geoffrey M ^c   Hann, Christopher E ^b   Geoffrey Chase, J ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF CANTERBURY   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Blood glucose; Critical care; Insulin sensitivity; Insulin therapy; Model based control; Predictive performance; TGC; Tight blood glucose control

Indexed keywords

BLOOD GLUCOSE; CRITICAL CARE; INSULIN SENSITIVITY; INSULIN THERAPY; MODEL-BASED CONTROL; PREDICTIVE PERFORMANCE; TGC; TIGHT BLOOD GLUCOSE CONTROL;

BLOOD; FORECASTING; GLUCOSE; INSULIN; INTENSIVE CARE UNITS; MEASUREMENT ERRORS; MODEL PREDICTIVE CONTROL; NUTRITION; PHYSIOLOGY; POPULATION STATISTICS; TIME VARYING CONTROL SYSTEMS;

PHYSIOLOGICAL MODELS;

GLUCOSE; INSULIN;

ARTICLE; CRITICALLY ILL PATIENT; EXPERIMENTAL MODEL; GLYCEMIC CONTROL; HUMAN; INSULIN SENSITIVITY; INSULIN TREATMENT; INTENSIVE CARE UNIT; INTENSIVE CONTROL INSULIN NUTRITION GLUCOSE MODEL; KINETICS; MAJOR CLINICAL STUDY; NUTRITION;

BLOOD GLUCOSE; COMPUTER SIMULATION; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MODELS, BIOLOGICAL; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; THERAPY, COMPUTER-ASSISTED;

EID: 79955154658     PISSN: 01692607     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmpb.2010.12.008     Document Type: Article

References (100)

1. Van Den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 2001, 345(19):1359-1367.
2. Bistrian B. Hyperglycemia and infection: which is the chicken and which is the egg?. JPEN J. Parenter. Enteral Nutr. 2001, 25(4):180-181.
3. McCowen K., Friel C., Sternberg J., Chan S., Forse R., Burke P., Bistrian B. Hypocaloric total parenteral nutrition: effectiveness in prevention of hyperglycemia and infectious complications - a randomized clinical trial. Crit. Care Med. 2000, 28(11):3606-3611.
4. Schultz M.J., de Graaff M.J., Kuiper M.A., Spronk P.E. The new Surviving Sepsis Campaign recommendations on glucose control should be reconsidered. Intensive Care Med. 2008, 34(4):779-780. doi:10.1007/s00134-008-1027-6.
5. Van Den Berghe G., Wilmer A., Milants I., Wouters P.J., Bouckaert B., Bruyninckx F., Bouillon R., Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006, 55(11):3151-3159. doi:10.2337/db06-0855.
6. Preiser J.-C. NICE-SUGAR: the end of a sweet dream?. Crit. Care 2009, 13(3):143. doi:10.1186/cc7790.
7. Kalfon P., Preiser J.-C. Tight glucose control: should we move from intensive insulin therapy alone to modulation of insulin and nutritional inputs?. Crit. Care 2008, 12(3):156. doi:10.1186/cc6915.
8. Preiser J.-C., Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit. Care Med. 2007, 35(9 Suppl.):503-507. doi:10.1097/01.CCM.0000278046.24345.C7.
9. Chase J.G., Shaw G.M. Is there more to glycaemic control than meets the eye?. Crit. Care 2007, 11(4):160. doi:10.1186/cc6099.
10. Vanhorebeek I., Langouche L., Van Den Berghe G. Tight blood glucose control: what is the evidence?. Crit. Care Med. 2007, 35(Suppl.):S496-S502. doi:10.1097/01.CCM.0000278051.48643.91.
11. Moghissi E.S., Korytkowski M.T., DiNardo M., Einhorn D., Hellman R., Hirsch I.B., Inzucchi S.E., Ismail-Beigi F., Kirkman M.S., Umpierrez G.E. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr. Pract. 2009, 15(4):353-369.
12. Van Den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., Wijngaerden E.V., Bobbaers H., Bouillon R. Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 2006, 354(5):449-461. doi:10.1056/NEJMoa052521.
13. Chase J., Shaw G., Le Compte A.J., Lonergan T., Willacy M., Wong X., Lin J., Lotz T., Lee D., Hann C.E. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit. Care 2008, 12(2):49. doi:10.1186/cc6868.
14. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin. Proc. 2004, 79(8):992-1000.
15. The NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 2009, 360(13):1283-1297. doi:10.1056/NEJMoa0810625.
16. Shulman R., Finney S.J., O'Sullivan C., Glynne P.A., Greene R. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol. Crit. Care 2007, 11(4):R75. doi:10.1186/cc5964.
17. Brunkhorst F.M., Engel C., Bloos F., Meier-Hellmann A., Ragaller M., Weiler N., Moerer O., Gruendling M., Oppert M., Grond S., Olthoff D., Jaschinski U., John S., Rossaint R., Welte T., Schaefer M., Kern P., Kuhnt E., Kiehntopf M., Hartog C., Natanson C., Loeffler M., Reinhart K., for the German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N. Engl. J. Med. 2008, 358(2):125-139. doi:10.1056/NEJMoa070716.
18. De La Rosa G., Donado J., Restrepo A., Quintero A., González L., Saldarriaga N., Bedoya M., Toro J., Velásquez J., Valencia J., Arango C., Aleman P., Vasquez E., Chavarriaga J., Yepes A., Pulido W., Cadavid C., Grupo de Investigacion en Cuidado intensivo: GICI-HPTU Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit. Care 2008, 12(5):R120. doi:10.1186/cc7017.
19. Wiener R.S., Wiener D.C., Larson R.J. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008, 300(8):933-944. doi:10.1001/jama.300.8.933.
20. Treggiari M., Karir V., Yanez N., Weiss N. Intensive insulin therapy and mortality in critically ill patients. Crit. Care 2008, 12(1):R29.
21. Griesdale D.E.G., de Souza R.J., van Dam R.M., Heyland D.K., Cook D.J., Malhotra A., Dhaliwal R., Henderson W.R., Chittock D.R., Finfer S., Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009, 180(8):821-827. doi:10.1503/cmaj.090206.
22. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414(6865):813-820. doi:10.1038/414813a.
23. Hirsch I., Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control?. J. Diabetes Complications 2005, 19(3):178-181.
24. Egi M., Bellomo R., Stachowski E., French C., Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105(2):244-252.
25. Chase J.G., Andreassen S., Jensen K., Shaw G.M. Impact of human factors on clinical protocol performance: a proposed assessment framework and case examples. J. Diabetes Sci. Technol. 2008, 2(3):409-416.
26. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am. J. Crit. Care 2006, 15(4):370-377.
27. Chase J.G., Shaw G.M., Lotz T., Le Compte A.J., Wong J., Lin J., Lonergan T., Willacy M., Hann C.E. Model-based insulin and nutrition administration for tight glycaemic control in critical care. Curr. Drug Deliv. 2007, 4(4):283-296.
28. Chase J.G., Shaw G., Wong X., Lotz T., Lin J., Hann C.E. Model-based glycaemic control in critical care - a review of the state of the possible. Biomed. Signal Process. Control 2006, 1(1):3-21.
29. Hovorka R., Kremen J., Blaha J., Matias M., Anderlova K., Bosanska L., Roubicek T., Wilinska M.E., Chassin L.J., Svacina S., Haluzik M. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J. Clin. Endocrinol. Metab. 2007, 92(8):2960-2964. doi:10.1210/jc.2007-0434.
30. Le Compte A., Chase J.G., Lynn A., Hann C.E., Shaw G., Wong X.-W., Lin J. Blood glucose controller for neonatal intensive care: virtual trials development and first clinical trials. J. Diabetes Sci. Technol. 2009, 3(5):1066-1081.
31. Mari A., Valerio A. A circulatory model for the estimation of insulin sensitivity. Control Eng. Pract. 1997, 5(12):1747-1752.
32. Bergman R., Phillips L., Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J. Clin. Invest. 1981, 68(6):1456-1467.
33. Parker R.S., Doyle F.J. Control-relevant modeling in drug delivery. Adv. Drug Deliv. Rev. 2001, 48(2-3):211-228.
34. Hovorka R., Chassin L.J., Ellmerer M., Plank J., Wilinska M.E. A simulation model of glucose regulation in the critically ill. Physiol. Meas. 2008, 29(8):959-978. doi:10.1088/0967-3334/29/8/008.
35. Hovorka R., Chassin L.J., Wilinska M.E., Canonico V., Akwi J.A., Federici M.O., Massi-Benedetti M., Hutzli I., Zaugg C., Kaufmann H., Both M., Vering T., Schaller H.C., Schaupp L., Bodenlenz M., Pieber T.R. Closing the loop: the adicol experience. Diabetes Technol. Ther. 2004, 6(3):307-318. doi:10.1088/0967-3334/29/8/008.
36. Wong X., Singh-Levett I., Hollingsworth L., Shaw G., Hann C.E., Lotz T., Lin J., Wong O., Chase J.G. A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol. Ther. 2006, 8(2):174-190.
37. Lin J., Lee D., Chase J.G., Shaw G.M., Le Compte A.J., Lotz T., Wong J., Lonergan T., Hann C.E. Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput. Methods Programs Biomed. 2008, 89(2):141-152. doi:10.1016/j.cmpb.2007.04.006.
38. Lotz T.F., Chase J.G., McAuley K.A., Shaw G.M., Wong X.-W., Lin J., Le Compte A.J., Hann C.E., Mann J.I., Monte Carlo analysis of a new model-based method for insulin sensitivity testing. Comput. Methods Programs Biomed. 2008, 89(3):215-225. doi:10.1016/j.cmpb.2007.03.007.
39. Hann C.E., Chase J.G., Lin J., Lotz T., Doran C.V., Shaw G.M. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput. Methods Programs Biomed. 2005, 77(3):259-270. doi:10.1016/j.cmpb.2004.10.006.
40. Lin J., Lee D., Chase J., Shaw G., Hann C.E., Lotz T., Wong J. Stochastic modelling of insulin sensitivity variability in critical care. Biomed. Signal Process. Control 2006, 1(3):229-242. doi:10.1016/j.bspc.2006.09.003.
41. Lotz T., Chase J.G., McAuley K., Lee D., Lin J., Hann C.E., Mann J. Transient and steady-state euglycemic clamp validation of a model for glycemic control and insulin sensitivity testing. Diabetes Technol. Ther. 2006, 8(3):338-346.
42. Lotz T., Göltenbott U., Chase J.G., Docherty P., Hann C.E. A minimal C-peptide sampling method to capture peak and total prehepatic insulin secretion in model-based experimental insulin sensitivity studies. J. Diabetes Sci. Technol. 2009, 3(4):875-886.
43. Docherty P.D., Chase J.G., Lotz T., Hann C.E., Shaw G.M., Berkeley J., Mann J.I., McAuley K.A. DISTq: an iterative analysis of glucose data for low-cost, real-time and accurate estimation of insulin sensitivity. Open Med. Inform. J. 2009, 3:65-76. ISSN 1874-4311.
44. Chase J.G., Shaw G., Lin J., Doran C., Hann C.E., Robertson M., Browne P., Lotz T., Wake G., Broughton B. Adaptive bolus-based targeted glucose regulation of hyperglycaemia in critical care. Med. Eng. Phys. 2005, 27(1):1-11.
45. Lonergan T., Le Compte A.J., Willacy M., Chase J.G., Shaw G.M., Wong X.-W., Lotz T., Lin J., Hann C.E. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol. Ther. 2006, 8(2):191-206. doi:10.1089/dia.2006.8.191.
46. Lonergan T., Le Compte A.J., Willacy M., Chase J.G., Shaw G.M., Wong X.-W., Lotz T., Lin J., Hann C.E. A pilot study of the SPRINT protocol for tight glycaemic control in critically ill patients. Diabetes Technol. Ther. 2006, 8(4):449-462.
47. Doran C., Hudson N., Moorhead K., Chase J.G., Shaw G., Hann C.E. Derivative weighted active insulin control modelling and clinical trials for ICU patients. Med. Eng. Phys. 2004, 26(10):855-866.
48. Blakemore A., Wang S.-H., Le Compte A.J., Shaw G.M., Wong X.-W., Lin J., Lotz T., Hann C.E., Chase J.G. Model-based insulin sensitivity as a sepsis diagnostic in critical care. J. Diabetes Sci. Technol. 2008, 2(3):177-468.
49. Chase J., Andreassen S., Pielmeier U., Hann C.E., McAuley K., Mann J. A glucose-insulin pharmacodynamic surface modeling validation and comparison of metabolic system models. Biomed. Signal Process. Control 2009, 4(4):355-363.
50. Thorsteinsson B. Kinetic models for insulin disappearance from plasma in man. Dan. Med. Bull. 1990, 37(2):143-153.
51. Ferrannini E., Cobelli C. The kinetics of insulin in man. II. Role of the liver. Diabetes Metab. Rev. 1987, 3(2):365-397.
52. Ferrannini E., Cobelli C. The kinetics of insulin in man. I. General spects. Diabetes Metab. Rev. 1987, 3(2):335-363.
53. Toffolo G., Campioni M., Basu R., Rizza R., Cobelli C. A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. Am. J. Physiol. Endocrinol. Metab. 2006, 290(1):E169-E176.
54. Van Cauter E., Mestrez F., Sturis J., Polonsky K. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992, 41(3):368-377.
55. Wong X.-W., Chase J.G., Hann C.E., Lotz T.F., Lin J., Le Compte A.J., Shaw G.M. Development of a clinical type 1 diabetes metabolic system model and in silico simulation tool. J. Diabetes Sci. Technol. 2008, 2(3):424-435.
56. Hasselbalch S.G., Knudsen G.M., Videbaek C., Pinborg L.H., Schmidt J.F., Holm S., Paulson O.B. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes 1999, 48(10):1915-1921.
57. Hasselbalch S.G., Madsen P.L., Knudsen G.M., Holm S., Paulson O.B. Calculation of the FDG lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans. J. Cereb. Blood Flow Metab. 1998, 18(2):154-160.
58. Hasselbalch S.G., Madsen P.L., Hageman L.P., Olsen K.S., Justesen N., Holm S., Paulson O.B. Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am. J. Physiol. 1996, 270(5 Pt 1):746-751.
59. Baron A.D., Brechtel G., Wallace P., Edelman S.V. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am. J. Physiol. 1988, 255(6 Pt 1):E769-E774.
60. Takeshita H., Okuda Y., Sari A. The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology 1972, 36(1):69-75.
61. Cohen P.J., Alexander S.C., Smith T.C., Reivich M., Wollman H. Effects of hypoxia and normocarbia on cerebral blood flow and metabolism in conscious man. J. Appl. Physiol. 1967, 23(2):183-189.
62. Strauss G., Moller K., Larsen F., Kondrup J., Knudsen G.M. Cerebral glucose and oxygen metabolism in patients with fulminant hepatic failure. Liver Transplant. 2003, 9(12):1244-1252.
63. Hattori N., Huang S.-C., Wu H.-M., Yeh E., Glenn T.C., Vespa P.M., McArthur D., Phelps M.E., Hovda D.A., Bergsneider M. Correlation of regional metabolic rates of glucose with glasgow coma scale after traumatic brain injury. J. Nucl. Med. 2003, 44(11):1709-1716.
64. Bingham E.M., Hopkins D., Smith D., Pernet A., Hallett W., Reed L., Marsden P.K., Amiel S.A. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 2002, 51(12):3384-3390.
65. McCarthy A.M., Elmendorf J.S. GLUT4's itinerary in health & disease. Indian J. Med. Res. 2007, 125(3):373-388.
66. Foster L.J., Klip A. Mechanism and regulation of GLUT-4 vesicle fusion in muscle and fat cells. Am. J. Physiol. Cell Physiol. 2000, 279(4):877-890.
67. Bryant N.J., Govers R., James D.E. Regulated transport of the glucose transporter GLUT4. Nat. Rev. Mol. Cell Biol. 2002, 3(4):267-277. doi:10.1038/nrm782.
68. Andersen S.K., Gjedsted J., Christiansen C., Tønnesen E. The roles of insulin and hyperglycemia in sepsis pathogenesis. J. Leukoc. Biol. 2004, 75(3):413-421. doi:10.1189/jlb.0503195.
69. Duckworth W.C., Bennett R.G., Hamel F.G. Insulin degradation: progress and potential. Endocr. Rev. 1998, 19(5):608-624.
70. T. Lotz, High resolution clinical model-based assessment of insulin sensitivity, PhD thesis, Mechanical Engineering, University of Canterbury, Christchurch, New Zealand.
71. Gudbjörnsdóttir S., Sjöstrand M., Strindberg L., Wahren J., Lönnroth P. Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscle. J. Clin. Endocrinol. Metab. 2003, 88(10):4559-4564.
72. Sjöstrand M., Holmäng A., Lönnroth P. Measurement of interstitial insulin in human muscle. Am. J. Physiol. 1999, 276(1 Pt 1):E151-E154.
73. Sjostrand M., Holmang A., Strindberg L., Lonnroth P. Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects. Am. J. Physiol. Endocrinol. Metab. 2000, 279(5):E1097-E1103.
74. Tappy L., Berger M., Schwarz J.M., McCamish M., Revelly J.P., Schneiter P., Jéquier E., Chioléro R. Hepatic and peripheral glucose metabolism in intensive care patients receiving continuous high- or low-carbohydrate enteral nutrition. JPEN J. Parenter. Enteral Nutr. 1999, 23(5):260-267.
75. Chambrier C., Laville M., Rhzioual Berrada K., Odeon M., Boulétreau P., Beylot M. Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin. Sci. 2000, 99(4):321-328.
76. Cobelli C., Caumo A., Omenetto M. Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model. Am. J. Physiol. 1999, 277(3 Pt 1):481-488.
77. McDonald C., Dunaif A., Finegood D. Minimal-model estimates of insulin sensitivity are insensitive to errors in glucose effectiveness. J. Clin. Endocrinol. Metab. 2000, 85(7):2504-2508.
78. Pillonetto G., Sparacino G., Magni P., Bellazzi R., Cobelli C. Minimal model SI=0 problem in NIDDM subjects: nonzero Bayesian estimates with credible confidence intervals. Am. J. Physiol. Endocrinol. Metab. 2002, 282(3):E564-E573.
79. Chase J.G., Shaw G.M., Lin J., Doran C.V., Bloomfield M., Wake G.C., Broughton B., Hann C., Lotz T. Impact of insulin-stimulated glucose removal saturation on dynamic modelling and control of hyperglycaemia. Int. J. Intell. Syst. Technol. Appl. (IJISTA) 2004, 1(1/2):79-94.
80. Dalla Man C., Caumo A., Basu R., Rizza R., Toffolo G., Cobelli C. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am. J. Physiol. Endocrinol. Metab. 2004, 287(4):E637-E643.
81. Avogaro A., Vicini P., Valerio A., Caumo A., Cobelli C. The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects. Am. J. Physiol. 1996, 270(3 Pt 1):E532-E540.
82. Caumo A., Cobelli C. Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model. Am. J. Physiol. 1993, 264(5 Pt 1):E829-E841.
83. Mari A., Wahren J., DeFronzo R.A., Ferrannini E. Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. Metab. Clin. Exp. 1994, 43(11):1419-1425.
84. Araujo-Vilar D., Rega-Liste C.A., Garcia-Estevez D.A., Sarmiento-Escalona F., Mosquera-Tallon V., Cabezas-Cerrato J. Minimal model of glucose metabolism: modified equations and its application in the study of insulin sensitivity in obese subjects. Diabetes Res. Clin. Pract. 1998, 39(2):129-141.
85. Picchini U., Gaetano A.D., Panunzi S., Ditlevsen S., Mingrone G. A mathematical model of the Euglycemic Hyperinsulinemic Clamp. Theor. Biol. Med. Model 2005, 2:44.
86. Ruiz-Velázquez E., Femat R., Campos-Delgado D. Blood glucose control for type I diabetes mellitus: a robust tracking H∞ problem. Control Eng. Pract. 2004, 12:1179-1195.
87. Silber H.E., Jauslin P.M., Frey N., Gieschke R., Simonsson U.S.H., Karlsson M.O. An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations. J. Clin. Pharmacol. 2007, 47(9):1159-1171. doi:10.1177/0091270007304457.
88. Cherrington A.D., Edgerton D., Sindelar D.K. The direct and indirect effects of insulin on hepatic glucose production in vivo. Diabetologia 1998, 41(9):987-996.
89. Mevorach M., Giacca A., Aharon Y., Hawkins M., Shamoon H., Rossetti L. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J. Clin. Invest. 1998, 102(4):744-753.
90. Monzillo L.U., Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr. Rev. 2003, 61(12):397-412.
91. Cherrington A. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 1999, 48(5):1198-1214.
92. Elahi D., Meneilly G., Minaker K., Andersen D., Rowe J. Escape of hepatic glucose production during hyperglycemic clamp. Am. J. Physiol. 1989, 257(5 Pt 1):E704-E711.
93. Mizock B. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract. Res. Clin. Endocrinol. Metab. 2001, 15(4):533-551.
94. Thorell A., Rooyackers O., Myrenfors P., Soop M., Nygren J., Ljungqvist O. Intensive insulin treatment in critically ill trauma patients normalizes glucose by reducing endogenous glucose production. J. Clin. Endocrinol. Metab. 2004, 89(11):5382-5386.
95. Dungan K.M., Braithwaite S.S., Preiser J.-C. Stress hyperglycaemia. Lancet 2009, 373(9677):1798-1807.
96. Poulin R., Steil G., Moore D., Ader M., Bergman R. Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes 1994, 43(2):180. (11).
97. Natali A., Gastaldelli A., Camastra S., Sironi A., Toschi E., Masoni A., Ferrannini E., Mari A. Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. Am. J. Physiol. Endocrinol. Metab. 2000, 278(5):E794-801.
98. Turnheim K., Waldhausl W. Essentials of insulin pharmacokinetics. Wien. Klin. Wochenschr. 1988, 100(3):65-72.
99. Doran C., Chase J.G., Shaw G., Moorhead K., Hudson N. Automated insulin infusion trials in the intensive care unit. Diabetes Technol. Ther. 2004, 6(2):155-165.
100. Parker R.S., Doyle F.J., Peppas N.A. The intravenous route to blood glucose control. IEEE Eng. Med. Biol. Mag. 2001, 20(1):65-73.